Participated · Series A · Jul 2026

Telum Therapeutics, founded in 2019, is developing protein-based antimicrobial therapies using its proprietary APEX platform. Its lead programme targets severe infections caused by Acinetobacter baumannii, specifically hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP). The company plans to use the Series A proceeds to complete Phase 1 clinical development of the lead candidate and to advance its broader pipeline against both Gram-negative and Gram-positive pathogens. Telum positions its approach as potentially overcoming limitations of existing antibiotic treatments. No revenue, user, or other operating metrics were disclosed in the announcement. The company highlighted support from both public and private Spanish and international investors as part of its financing.

Participated · Series B · Jun 2026

Ona Therapeutics is a spin-off from IRB Barcelona and ICREA that develops precision-engineered antibody-drug conjugates (ADCs) to target treatment-resistant cancers. The company uses a proprietary, patient-driven discovery platform to identify tumor-specific antigens and epitopes that enable efficient internalization and targeted payload delivery. Its lead clinical program is ONA-255, initially focused on breast cancer, and it is also advancing ONA-389 targeting colorectal cancer. The company integrates target validation, antibody engineering, optimized payload selection and validated linker-payload technologies in its ADC development approach. Led by CEO Valerie Vanhooren, Ona plans to use the Series B proceeds to advance clinical development of its lead and second programs. The article does not disclose revenue, user metrics or a company valuation.

Participated · Seed · Apr 2026

Golden Owl builds an intelligence operating system that fuses multi-source, multimodal data with AI-driven reasoning to generate actionable insights from complex and fragmented information environments. Its platform is designed to detect hidden patterns, influence networks, and early risk signals to support decision-making in sectors such as security, defense, and business strategy. The company offers products including Noctua and Strix, with an upcoming product named Otus. Golden Owl plans to expand its data ingestion across open, deep, and dark web sources and accelerate deployment across multiple sectors using its recent funding. Financially, it raised a €1.4 million Seed round in April 2026 led by First Drop, with support from ENISA, CDTI (NEOTEC grant), and business angels. The company is headquartered in Alicante, Spain.

Participated · Series B · Apr 2026

Founded in 2019, Xoople has developed a tech stack around government-collected spacecraft data and integrations with cloud providers, aiming to operate its own satellite constellation and optical sensors. The company has focused on data quality and embedding its data distribution into enterprise platforms such as Microsoft and Esri. Xoople recently signed a deal with L3Harris Technologies to begin building sensors for its spacecraft and says those systems will collect optical data. The startup faces established competitors that already operate satellites, including Vantor, Planet, BlackSky, and Airbus. Financially, Xoople has raised $225 million to date, including a $130 million Series B led by Nazca Capital. Management has said it continues to raise capital to fund full development and declined to disclose a valuation, noting they are “in unicorn territory.”

Participated · Equity · Mar 2026

IONLY develops and manufactures lithium batteries aimed at photovoltaic energy storage, producing its units entirely in Europe to reduce dependence on Asian suppliers. The company emphasizes a holistic product approach, from minimalist home-integrated design to technical support. With the new investment, IONLY intends to automate and robotize assembly to increase production capacity and operational efficiency. Management positions the batteries as a key piece for resilience in critical energy infrastructures in Europe. The founder and CEO is Alejandro Desco, who previously participated in EDEM and Lanzadera within the Marina de Empresas ecosystem. The recent €1.2M financing led by Angels improves the company’s financial position to pursue commercial growth and European expansion.